We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pacemakers Undo Valve Replacement Benefits

By HospiMedica International staff writers
Posted on 29 Dec 2011
Right ventricle pacing may undermine the benefits of transcatheter aortic-valve replacement (TAVI), according to a new study.

Researchers at the University of Bonn (Germany) conducted a prospective study involving 86 consecutive patients between 2008 and 2010 (38 male; mean age 80), with severe symptomatic aortic-valve stenosis and indication for TAVI. More...
Of these, 29 Patients (34%) had already had a pacemaker placed before TAVI, or needed one due to post-interventional AV-Block III. The study was designed to evaluate the effects of right ventricular pacing on left ventricular function after TAVI; follow up was after six months with echocardiography.

The results showed that left ventricular Tei-Index (LC-Tei) and systolic pulmonal-artery pressure, as well as left ventricular mass index and right ventricular indices, did not differ before TAVI in both groups. However, six months after TAVI left ventricular ejection fraction increased significantly in the group without permanent pacemaker, and was significantly different to the ejection fraction of the pacemaker group six months after TAVI. Systolic pulmonary artery pressure (sPAP), as well as LV-Tei were different between both groups after six months, but failed to show statistical significance. Left ventricular mass index and right ventricular indices did not differ before and six months after TAVI in both groups. The study was presented at EuroEcho 2011, held during December 2011 in Budapest (Hungary).

“If they need a pacemaker, they need it; and if they do not get the TAVI, they would probably die within one or two years. They need both,” said lead author and study presenter Marcel Weber, MD, and colleagues of the department of cardiology. “We have to watch the ejection fraction; if they don't get a better ejection fraction three months after TAVI then we have to consider a different device, a cardiac resynchronization device.”

TAVI involves the percutaneous insertion of a catheter containing a replacement valve at a site in the groin or the left chest. The new valve is pushed into the correct site, where the surgeon expands it and pushes the old one aside. The procedure is much less invasive than traditional open heart aortic valve replacement and does not require putting the patient on a heart and lung machine, so it can be performed on those who cannot have open heart surgery. In addition, data from recent trials suggest that this procedure might also be a viable option for patients who qualify for open-heart surgery, but who are considered high-risk surgical candidates.

Related Links:

University of Bonn




New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Digital Radiography System (Ceiling Free)
Digix CF Series
New
Desk Aneroid Sphyg
Diagnostix 750D+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Six-month FlexPulse IDE data show positive outcomes with Abbott’s TactiFlex Duo catheter, confirming safety and efficacy seen in the CE Mark study for complex AFib (photo courtesy of Abbott)

Dual-Energy Ablation and Conduction System Pacing Show Positive Early Outcomes

Atrial fibrillation and other arrhythmias are common in both hospitalized and ambulatory patients, often complicating hemodynamic stability, stroke prevention, and perioperative care. Within this context,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.